Table 1.
Category | Year | Title |
---|---|---|
Series on testing and assessment | 2012 | The AOP for skin sensitization initiated by covalent binding to proteins (series on Testing and Assessment No. 168) |
2013 | Guidance document on developing and assessing AOPs (series on Testing and Assessment No. 184) | |
Series on AOPs | 2016 | Users' handbook supplement to the guidance document for developing and assessing AOPs (OECD series on AOPs No. 1) |
2016 | AOP on protein alkylation leading to liver fibrosis (OECD series on AOPs No. 2) | |
2016 | AOP on alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations (OECD series on AOPs No. 3) | |
2016 | AOP on aromatase inhibition leading to reproductive dysfunction (in fish) (OECD series on AOPs No. 4) | |
2016 | AOP on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development induces impairment of learning and memory abilities (OECD series on AOPs No. 5) | |
2016 | AOP on binding of agonists to ionotropic glutamate receptors in adult brain leading to excitotoxicity that mediates neuro nal cell death, contributing to learning and memory impairment (OECD series on AOPs No. 6) |
AOP, adverse outcome pathway; OECD, Organization for Economic Cooperation and Development.